Disclosures for "Stratified Effectiveness and Safety of Fenfluramine in Dravet and Lennox-Gastaut Syndromes: A Retrospective Comparative Analysis of Trial and Open-label Extension Data (2018-2024)"
-
Miss Beniwal has nothing to disclose.
-
Dr. Sayed Mushir Ali has nothing to disclose.
-
Dr. da Costa has nothing to disclose.
-
Dr. Mehan has nothing to disclose.
-
Mr. Mahato has nothing to disclose.
-
Dr. Rawat has nothing to disclose.
-
Miss Franco Neiva has nothing to disclose.